ArticleFrontiers in pharmacology2025
Diacetyl-induced bronchiolitis obliterans involves ubiquitin C upregulation and fibrosis-related gene activation in rats.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regulation of immune checkpoints by electronic cigarette.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bronchiolitis obliterans (BO) is an irreversible, chronic obstructive pulmonary disease with inflammation and fibrosis causing bronchiolar narrowing. Inhaling diacetyl (DA) can result in BO in humans. Methods: We aimed to investigate the relationship between fibrosis-related gene expression and ubiquitin C (UbC) regulation in a rat model of BO following a single DA instillation, by examining lung histopathology, UbC protein levels, and transcriptomic changes. Results: After DA exposure, rat bronchioles exhibited marked inflammation, increased collagen deposition, airway fibrosis, and obstruction. These changes were confirmed by histology and semi-quantitative image analysis. UbC protein levels were significantly elevated in a time-dependent manner. RNA sequencing revealed significant alterations in gene expression and enrichment of multiple molecular functions and biological processes in BO rats compared with controls, including pathways related to fibrosis formation and ubiquitin dysregulation. Quantitative PCR (qPCR) validation further confirmed the transcriptomic results, showing significant upregulation of Ube2t and Fap and downregulation of Cyp1a1, consistent with enhanced ubiquitin activity, fibroblast activation, and impaired oxidative stress regulation. Discussion: These findings indicate that DA instillation induces early BO-like changes, disrupts ubiquitin regulation, and increases UbC expression, potentially through oxidative stress-related mechanisms. A better understanding of ubiquitin regulation (particularly UbC) may provide novel molecular targets for therapeutic intervention in BO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.